Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world multicenter study of roxadustat for anemia in chronic kidney disease
ChiCTR2100044135Phase 4Recruiting
- Sponsor
- Shenzhen People's Hospital
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of roxadustat in anemia of renal disease, sponsored by Shenzhen People's Hospital. Primary endpoints: Hemoglobin level change, Monthly costs due to adverse drug events and 1 more. Started Mar 2021; status: recruiting.
02
Drugs
roxadustat
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on ChiCTR2100044135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044135.